Company News, Financial News

NovaBay Pharmaceuticals Reports $3.1 Million in Net Product Revenue for Q1 2023

This includes $0.8 million of DERMAdoctor skincare product sales.

Author Image

By: Lianna Albrizio

Associate Editor

Net product revenue for NovaBay Pharmaceuticals in the first quarter of 2023 was $3.1 million, compared with $3.3 million for the prior-year period, the company reported.    This includes $2.2 million of Avenova-branded eyecare product sales, $0.8 million of DERMAdoctor skincare product sales and $0.1 million of PhaseOne wound care product sales.   Gross margin on net product revenue for the Q1 ‘23 improved to 62%, compared with 55% for the first quarter of 2022, with the increas...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters